Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.76% |
| 2 | Financials | 7.62% |
| 3 | Healthcare | 7.1% |
| 4 | Industrials | 5.08% |
| 5 | Consumer Discretionary | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Incyte
INCY
$24.4B
| $18.1M | 0.01% |
238,798
-272,549
| -53% | -$20.7M |
|
1402
Reliance Steel & Aluminium
RS
$21.6B
| $18.1M | 0.01% |
106,647
+83,773
| +366% | +$15.6M |
|
1403
Fate Therapeutics
FATE
$326M
| $18.1M | 0.01% |
729,771
+419,627
| +135% | +$11.6M |
|
1404
CALL
Manulife Financial
MFC
$73.5B
| $18.1M | 0.01% |
810,000
| – | – |
|
|
ACQR
1405
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
| $18.1M | 0.01% |
1,844,755
+38,360
| +2% | +$376K |
|
1406
Allstate
ALL
$67.5B
| $18M | 0.01% |
142,107
-895,787
| -86% | -$117M |
|
1407
PUT
Prudential Financial
PRU
$41.8B
| $18M | 0.01% |
188,200
-86,100
| -31% | -$9.11M |
|
1408
MSC Industrial Direct
MSM
$6.86B
| $18M | 0.01% |
239,453
+156,483
| +189% | +$12.8M |
|
|
HCP
1409
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $18M | 0.01% |
610,737
+354,725
| +139% | +$14.3M |
|
1410
McGrath RentCorp
MGRC
$2.92B
| $17.9M | 0.01% |
235,825
+89,174
| +61% | +$7.27M |
|
1411
Eagle Materials
EXP
$6.57B
| $17.9M | 0.01% |
162,572
-135,437
| -45% | -$16.7M |
|
1412
PUT
PNC Financial Services
PNC
$101B
| $17.8M | 0.01% |
112,600
-77,600
| -41% | -$13M |
|
1413
Saic
SAIC
$5.35B
| $17.7M | 0.01% |
190,459
+86,348
| +83% | +$7.55M |
|
|
FTPA
1414
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
| $17.7M | 0.01% |
1,802,853
| – | – |
|
|
NSTD
1415
DELISTED
Northern Star Investment Corp. IV
NSTD
| $17.7M | 0.01% |
1,804,791
+302,435
| +20% | +$2.96M |
|
1416
Cirrus Logic
CRUS
$6.26B
| $17.7M | 0.01% |
243,564
-860,237
| -78% | -$66.7M |
|
1417
Cathay General Bancorp
CATY
$4.24B
| $17.6M | 0.01% |
450,623
+293,265
| +186% | +$12M |
|
1418
NeoGenomics
NEO
$2.13B
| $17.6M | 0.01% |
2,164,263
+1,626,337
| +302% | +$15.5M |
|
1419
Jack in the Box
JACK
$335M
| $17.6M | 0.01% |
313,963
+307,248
| +4,576% | +$23.3M |
|
|
SWAV
1420
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $17.6M | 0.01% |
91,981
-497,905
| -84% | -$87.9M |
|
1421
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $17.6M | 0.01% |
236,542
-606,972
| -72% | -$45.6M |
|
1422
AngloGold Ashanti
AU
$48.7B
| $17.6M | 0.01% |
1,187,190
+729,600
| +159% | +$13.8M |
|
1423
Danaos Corp
DAC
$2.56B
| $17.5M | 0.01% |
277,982
+265,413
| +2,112% | +$21.3M |
|
1424
Merit Medical Systems
MMSI
$5.32B
| $17.5M | 0.01% |
322,572
-29,816
| -8% | -$1.82M |
|
1425
Vir Biotechnology
VIR
$1.49B
| $17.5M | 0.01% |
687,199
-4,060,995
| -86% | -$94.8M |
|
Similar funds
Millennium Management's Q2 2022 Portfolio in Review
As of Q2 2022, Millennium Management held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Millennium Management deployed $7.94B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 7.8% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Millennium Management's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Millennium Management added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Millennium Management's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Millennium Management fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Millennium Management's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Millennium Management opened 1,144 new positions and closed 1,065 in Q2 2022.
- Millennium Management's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.